ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 66 filers reported holding ONCOCYTE CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $55,000 | -19.1% | 75,120 | 0.0% | 0.04% | -18.9% |
Q2 2022 | $68,000 | -39.3% | 75,120 | 0.0% | 0.05% | -25.4% |
Q1 2022 | $112,000 | -21.1% | 75,120 | -0.3% | 0.07% | -27.6% |
Q4 2021 | $142,000 | -34.9% | 75,330 | +13.8% | 0.10% | -36.4% |
Q3 2021 | $218,000 | -36.8% | 66,200 | +10.3% | 0.15% | -36.9% |
Q2 2021 | $345,000 | +10.6% | 60,025 | 0.0% | 0.24% | +7.5% |
Q1 2021 | $312,000 | +280.5% | 60,025 | +74.2% | 0.23% | +183.8% |
Q4 2020 | $82,000 | – | 34,465 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 1,093,219 | $6,833,000 | 1.15% |
HUNTINGTON NATIONAL BANK | 10 | $0 | 0.00% |
CITIGROUP INC | 642 | $4,000 | 0.00% |
Sonora Investment Management, LLC | 50 | $0 | 0.00% |
BARCLAYS PLC | 206 | $1,000 | 0.00% |
BLACKROCK ADVISORS LLC | 96 | $1,000 | 0.00% |